GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Gross Profit

Abaxis (Abaxis) Gross Profit : $133.6 Mil (TTM As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Gross Profit?

Abaxis's gross profit for the three months ended in Mar. 2018 was $37.3 Mil. Abaxis's gross profit for the trailing twelve months (TTM) ended in Mar. 2018 was $133.6 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Abaxis's gross profit for the three months ended in Mar. 2018 was $37.3 Mil. Abaxis's Revenue for the three months ended in Mar. 2018 was $67.9 Mil. Therefore, Abaxis's Gross Margin % for the quarter that ended in Mar. 2018 was 54.96%.

Abaxis had a gross margin of 54.96% for the quarter that ended in Mar. 2018 => Durable competitive advantage


Abaxis Gross Profit Historical Data

The historical data trend for Abaxis's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Gross Profit Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.95 108.97 123.25 125.85 133.61

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.18 31.94 32.16 32.18 37.33

Competitive Comparison of Abaxis's Gross Profit

For the Diagnostics & Research subindustry, Abaxis's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Gross Profit distribution charts can be found below:

* The bar in red indicates where Abaxis's Gross Profit falls into.



Abaxis Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Abaxis's Gross Profit for the fiscal year that ended in Mar. 2018 is calculated as

Gross Profit (A: Mar. 2018 )=Revenue - Cost of Goods Sold
=244.7 - 111.091
=133.6

Abaxis's Gross Profit for the quarter that ended in Mar. 2018 is calculated as

Gross Profit (Q: Mar. 2018 )=Revenue - Cost of Goods Sold
=67.918 - 30.59
=37.3

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $133.6 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Abaxis's Gross Margin % for the quarter that ended in Mar. 2018 is calculated as

Gross Margin % (Q: Mar. 2018 )=Gross Profit (Q: Mar. 2018 ) / Revenue (Q: Mar. 2018 )
=(Revenue - Cost of Goods Sold) / Revenue
=37.3 / 67.918
=54.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Abaxis  (NAS:ABAX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Abaxis had a gross margin of 54.96% for the quarter that ended in Mar. 2018 => Durable competitive advantage


Abaxis Gross Profit Related Terms

Thank you for viewing the detailed overview of Abaxis's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020